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Objective: To investigate the speciﬁc role of Frizzled-related protein (FRZB) and Secreted frizzled-related
protein 1 (SFRP1) in the onset and progression of Osteoarthritis (OA) using Frzb/ and Sfrp1/ mice in
the destabilization of medial meniscus model (DMM), a slowly progressing model of OA. Secreted
frizzled-related proteins (SFRPs) were identiﬁed as secreted Wingless-type (Wnt) antagonists. The Wnt
signaling cascade is a major regulator in cartilage development, homeostasis and degeneration.
Methods: The DMM model was surgically induced in eight-week-old male C57/Bl6 Frzb/, Sfrp1/ or
wild-type mice by transection of the medial meniscotibial ligament. Cartilage damage in the femoral and
tibial articular surfaces was calculated following the Osteoarthritis Research Society International
(OARSI) histopathology initiative guidelines. Histomorphometry was used to evaluate the subchondral
bone plate thickness.
Results: OA severity scores were signiﬁcantly higher in the tibia of Frzb/ mice as compared to litter-
mates, whereas no interaction was seen between genotype and intervention in Sfrp1/ mice. Moreover,
the DMM model resulted in signiﬁcantly greater subchondral bone changes compared to sham but was
not different between Frzb/ mice and littermates. In contrast, the subchondral bone properties in
Sfrp1/ mice were signiﬁcantly different from littermates.
Conclusion: Using the DMM model, we demonstrated that FRZB and SFRP1 differentially modulate joint
homeostasis in two distinct compartments of the joint. These data highlight the ﬁne-tuning of Wnt
signaling in joint homeostasis and disease, show differential regulation of the cascade in cartilage and
subchondral bone, and provide further evidence for a role of endogenous Wnt modulators as key players
in OA.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a chronic and progressive joint disorder
characterized by structural damage to one or more joints. Symp-
toms vary frommild to severe joint pain and stiffness, often leading
to loss of joint function and permanent disability. Genetic as well as
acquired factors, including trauma and life-style associated features
such as obesity contribute to the disease. OA is considered a disease
of the whole joint: in addition to the articular cartilage, theo: R.J. Lories, Laboratory of
e Box 813, Herestraat 49,
6-342543.
(S. Thysen), Frank.Luyten@uz.
R.J. Lories).
ternational. Published by Elsevier Lsubchondral bone and synovium also play important roles in onset
and progression of OA. In early stages cell proliferation and
enhanced matrix remodeling occur simultaneously in both carti-
lage and bone. When the balance between anabolic and catabolic
processes in the joint is lost, the remodeling response results in
articular cartilage degradation, osteophyte formation and sub-
chondral bone sclerosis. The latter is associated with reduced
mineralization secondary to increased tissue turnover and leading
to impaired bone quality1.
Polymorphisms in Frizzled-related protein (FRZB/SFRP3) have
been associated with OA2, although this has been challenged more
recently in genetic studies of very large cohorts3. Nevertheless,
mice with loss of Frzb show increased severity of OA in different
acute models4. FRZB is a member of the secreted frizzled-related
protein (SFRP) family, which includes ﬁve members (SFRP1-5).td. All rights reserved.
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inhibitors of the Wingless-type (Wnt) signaling cascade. More
recent data suggest that SFRPs have a broad range of biological
activities, including negative and positive modulation of Wnt
signaling and additional interactions with molecules that are un-
related to Wnt signaling5. The Wnt signaling cascade is a major
regulator of the development and growth of bone and cartilage6.
Finely tunedWnt signaling is required tomaintain the integrity and
homeostasis of the bone-cartilage unit. Therefore, disregulation of
Wnt signaling can lead to OA development6e8.
Frzb/ and Sfrp1/mice have contrasting skeletal phenotypes:
Frzb/ mice show increased cortical thickness without changes in
the trabecular bone4, whereas increased trabecular but normal
cortical bone is observed in Sfrp1 deﬁcient mice9. The role of SFRP1
in OA has not been studied. In this study, we therefore investigated
the role of both FRZB and SFRP1 in the onset and progression of OA
using Frzb/ and Sfrp1/ mice in the destabilization of medial
meniscus model (DMM) of OA, a model with relatively slow disease
progression offering an excellent translational perspective on OA
development.
Materials and methods
Mice
Frzb/ mice4 were backcrossed onto the C57BL/6 background
for more than 10 generations. Sfrp1/ C57/Bl6 mice were a gift
from J. Rubin (Bethesda, MD, USA). These mice were compared to
age matched C57BL/6 littermates. The animals were housed in
conventional conditions: 12-h light/dark cycle, standard diet
(1% calcium, 0.76% phosphate) and water ad libitum. All experi-
ments were approved by the Ethical Committee for animal research
at KU Leuven (P198/2012).
DMM model in mice
The DMM model of OA was surgically induced in the right knee
of eight-week-old male Frzb/ (n ¼ 16), Sfrp1/ (n ¼ 10) or wild-
type mice (n ¼ 12 and n ¼ 16) by transection of the medial
meniscotibial ligament10. Sham-operated knees (Frzb/ (n ¼ 13),
Sfrp1/ (n¼ 6) or wild-typemice (n¼ 13 and n¼ 18)) were used as
control. Eight weeks after surgery, mice were sacriﬁced and knees
were dissected for histology. Knee sections (ﬁve sections, 100 mm
apart) were stained with hematoxylin-eosin and Safranin O.
Cartilage damage in the femoral and tibial articular surfaces was
quantiﬁed following the Osteoarthritis Research Society Interna-
tional (OARSI) histopathology initiative guidelines in a blinded
fashion11.
Subchondral bone plate histomorphometry
Histomorphometry was performed on Safranin-O- stained sec-
tions using an Olympus DP73microscope and digital image analysis
using Osteomeasure software. First, a box with a ﬁxed width
(800 mM) and variable height with the upper limit at the transition
of calciﬁed cartilage to subchondral bone and the lower limit at the
transition subchondral bone to growth plate was created from the
digital image (referred to as subchondral bone area, area deﬁned by
blue line in [Fig. 2(A)]. Next, a new box with the upper limit
matched to the ﬁrst box and the lower limit at the transition of the
subchondral bone plate to trabecular bone was generated (referred
to as subchondral bone plate area, area deﬁned by white line in
[Fig. 2(A)]. The lined surface areas were calculated using the
Osteomeasure software. To correct for variances due to section ar-
tifacts, we do not show the subchondral bone plate surface areaper se, but express the subchondral bone plate thickness as a ratio of
the subchondral bone plate area to the subchondral bone area.
Immunohistochemistry
Procedures and materials used for immunohistochemistry are
presented in Supplementary Materials.
Statistics
All analyses were performed with GraphPad Prism. We hy-
pothesized that the dependent variables (OA severity and sub-
chondral bone plate thickness) could be determined by two
independent variables (genotype and surgery) and therefore tested
the effect of genotype, surgical intervention and their interaction
using 2-way analysis of variance (ANOVA). The assumptions un-
derlying the ANOVA were assessed: the dependent variables were
measured at a ratio level and the independent variables were cat-
egorical, independent and based on independent observations. For
subchondral bone plate analysis, data were normally distributed in
the SFRP1 experiment based on visual analysis and the D'Agostino
e Pearson omnibus normality test. In the FRZB experiment one
outlier was identiﬁed by the Grubbs method affecting the normal
distribution. Removal of the outlier resulted in a normal distribu-
tion assessed as above. Four-group analyses in both setups sug-
gested homogeneity of variance for both original and cleaned
datasets based on the BrowneForsythe test. For OA severity anal-
ysis, data were not normally distributed and there was no homo-
geneity of variance. We therefore performed a log transformation
of the scores resulting in positive assessment of the normal dis-
tribution for the different datasets and homogeneity of variance
assessed as above. ROUTand Grubbsmethod did identify outliers in
both the FRZB and SFRP1 experiments. 2-way ANOVA was per-
formed on original as well as cleaned datasets. Only the analysis of
the original data is reported as removal of outliners emphasized
detected differences with smaller 95% conﬁdence intervals (CIs) of
differences between means. If a signiﬁcant interaction was detec-
ted, post-hoc Sidak test taking into account multiple comparisons
was applied. Data are presented as mean þ 95% CI and P-
values < 0.05 were considered signiﬁcant. In the post-hoc tests,
adjusted P-values < 0.05 correspond with 95% CI for differences
between means that do not contain the zero value.
Results
To study the role of SFRPs in a slowly progressing model of OA,
the DMM model was induced in Frzb/, Sfrp1/ and wild-type
mice. 8-weeks after induction, OA severity scores were signiﬁ-
cantly higher in the tibia of Frzb/ mice as compared to litter-
mates (2-way ANOVA) P ¼ 0.0105 for interaction between
genotype and intervention e P < 0.05 between Frzb/ and
littermates in DMM but not sham intervention with difference
between means respectively 0.431 (95CI: 0.838; 0.024) for
DMM and 0.254 (95%CI: 0.18; 0.687) for Sham (Sidak test). For
the femur overall scoring was lower compared to tibia. DMMmice
had signiﬁcantly higher scores than sham-operated animals, but
there was no interaction with the speciﬁc genotype. These data
correspond with the OARSI position paper11 indicating that the
scoring of the femoral condyl is more challenging due to thinner
cartilage, the deﬁnition of the tidemark and the convex shape of
the condyles, hence leading to lower overall scores and larger error
margins.
For the Sfrp1/ mice as compared to littermates no interaction
between genotype and intervention was seen at either the tibia or
femur (Fig. 1).
Fig. 1. Loss of Frzb increases cartilage damage in DMM model of OA. (A) Representative frontal hematoxylin-Safranin O stained sections of wild-type, Frzb/ and Sfrp1/ knees
(medial condyle) in the DMM model or sham-operated. Bar ¼ 100 mM, original magniﬁcation 20. Arrows indicate cartilage ﬁbrillation, triangles indicate loss of proteoglycans and
asterisks indicate loss of cartilage. (B) Quantiﬁcation of articular cartilage erosion in wild-type, Frzb/ and Sfrp1/ mice, subjected to either sham or DMM. The medial condyle of
tibia and femur were evaluated by the OARSI scoring system. Data are shown as the maximum histologic scoreþ95% CI. Left: WT sham-operated (n ¼ 13), WT DMM (n¼ 12), Frzb/
sham-operated (n ¼ 13) and Frzb/ DMM (n ¼ 16). 2-way ANOVA P < 0.05 for genotype, intervention and interaction e P < 0.05 between Frzb/ and littermates (Sidak test). Right:
WT sham-operated (n ¼ 18), WT DMM (n ¼ 16), Sfrp1/ sham-operated (n ¼ 6) and Sfrp1/ DMM (n ¼ 10).
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medial tibial plateau of DMM-induced and sham-operated mice by
histologic assessment at 8-weeks post surgery. The DMM model
resulted in signiﬁcantly greater subchondral bone changes
compared to sham but was not different between Frzb/mice and
littermates ((2-way ANOVA) P < 0.05 for intervention only). In
contrast, the subchondral bone properties in Sfrp1/ mice were
signiﬁcantly different from littermates ((2-way ANOVA) P ¼ 0.04
for interaction between genotype and intervention) (Fig. 2). Sidak
test returned a P-value equal to 0.06 for the difference between
Sfrp1/ mice and littermates in the DMM model with the differ-
ence between means respectively 6,26 (95%CI: 12.79; 0.268) for
DMM and 3.147 (95%CI: 5.189; 11.483) for sham.
FRZB immunohistochemical staining indicated the presence of
FRZB in the deep layer of the articular cartilage in wild-type mice
(Supplementary Fig. 1(A)/2(A)), as previously was also observed for
human cartilage12. This staining was absent in Frzb/ mice and
appeared reduced in Sfrp1/ mice. We could not observe any Frzb
in the subchondral bone of wild-type, Frzb/ and Sfrp1/ mice.
Total beta-catenin staining was primarily located in the superﬁcial
layers of the articular cartilage (Supplementary Fig. 1(B)/2(B)). The
staining suggested that more beta-catenin was present in Frzb/
mice upon DMM surgery compared to sham-operated, whereas the
opposite is true for Sfrp1/ mice. These data complement our
ﬁndings that Frzb/ and Sfrp1/ show different phenotypes upon
DMM induction and may suggest that these ﬁndings are at leastpartly due to differences in canonical Wnt signaling. Due to tech-
nical limitations we could not achieve successful SFRP1 staining.
Discussion
Using the DMM model, we demonstrate that FRZB and SFRP1
differentially modulate joint homeostasis in two distinct com-
partments of the joint. These data highlight the relevance of Wnt
signaling in joint surface and subchondral bone biology, and pro-
vide further evidence for a role of endogenous Wnt modulators as
key players in these processes. Earlier in vivo data demonstrate that
Frzb/mice are more prone to cartilage damage in different short-
term models of OA4. Transcriptome analysis of the bone-cartilage
unit in joints of Frzb/ mice further revealed that the Wnt
pathway is tightly regulated with compensatory upregulation of
other Wnt modulators in the absence of Frzb. Moreover, in vitro
studies highlight the key function for Frzb in cartilage homeosta-
sis13. Although Frzb/ mice are reported with increased cortical
bone thickness and density4, loss of Frzb did not lead to an increase
of subchondral bone plate thickness compared to control in the
DMM model.
Targeted inactivation of another member of the SFRP family,
Sfrp1, did not lead to increased cartilage degeneration upon DMM.
However, we could observe thickening of the subchondral bone
plate compared to control. The anabolic effect of loss of Sfrp1 on the
subchondral bone is consistent with previous in vivo data. Genetic
Fig. 2. Loss of Sfrp1 increases subchondral bone plate thickness in DMM model of OA. (A) Representative frontal hematoxylin-Safranin O stained sections of wild-type, Frzb/ and
Sfrp1/ knees (medial condyle) in the DMM model or sham-operated. Blue line delineates the subchondral bone area and white lines delineate the subchondral bone plate
thickness. Bar ¼ 100 mM, original magniﬁcation 10. (B) Quantiﬁcation of the subchondral bone plate. Data are shown as the mean ratio of subchondral bone plate area/subchondral
bone area þ 95% CI. Left: WT sham-operated (n ¼ 20), WT DMM (n ¼ 16), Frzb/ sham-operated (n ¼ 12) and Frzb/ DMM (n ¼ 13) (2-way ANOVA P < 0.05 for intervention only).
Right: WT sham-operated (n ¼ 20), WT DMM (n ¼ 16), Sfrp1/ sham-operated (n ¼ 5) and Sfrp1/ DMM (n ¼ 11) (2-way ANOVA P < 0.05 for intervention and interaction).
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osteoblast and osteocyte apoptosis14. Sfrp1 may also inhibit osteo-
clastogenesis by binding of nuclear factor-kappaB ligand (RANKL), a
ligand that is expressed by osteoblastic cells and promotes osteo-
clast differentiation through interaction with their cognate
signaling receptor RANK15. Our data may imply that Sfrp1 plays
mainly a role in the subchondral bone and not in the homeostasis of
articular cartilage during OA.
Previous studies by Zhu et al. already highlighted how Wnt
signaling can affect joint homeostasis with both gain and loss offunction for key signalingmediator beta-catenin resulting inOA-like
phenotypes7,8. Although the SFRP family has originally been iden-
tiﬁed as extracellular Wnt antagonists, it has become increasingly
clear that they should be regarded as Wnt modulators (both in a
positive and negative way) and that their interactome extends
beyond Wnt ligands5.
Finally, the differential effects of loss of SFRP1 and FRZB on
cartilage and subchondral bone in this model suggest that, at least
in the initial phase of disease, cartilage and subchondral bone
remodeling may be uncoupled or at least modulated by distinct
S. Thysen et al. / Osteoarthritis and Cartilage 23 (2015) 275e279 279molecules belonging to the same family. In the context of this study,
this could be partly explained by the difference in the expression
proﬁle of FRZB and SFRP1.Whereas Frzb is predominantly expressed
postnatally in the cartilage and periosteum of mice4, Sfrp1 expres-
sion is observed in cartilage13 but appears most important in oste-
oblast differentiation14. Taken together this accumulating evidence
further highlights the potential of Wnt signaling modulation in the
joint as a therapeutic target but at the same time demonstrates the
critical role of themicroenvironment in determining the outcome of
the disease processes.
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